Iron Deficiency Anaemia. Other iron deficiency anaemias, Iron deficiency anaemia, unspecified
Conditions
Interventions
Intervention 1: Intervention group: 100 mg intravenous Venofer, three times weekly at the end of each dialysis sessions for seven weeks. Intervention 2: Control group: Ferrous Sulfate tablet 50 mg dai
Treatment - Drugs
Intervention group: 100 mg intravenous Venofer, three times weekly at the end of each dialysis sessions for seven weeks
Control group: Ferrous Sulfate tablet 50 mg daily, for seven weeks
Sponsors
Vice chancellor for research, Golestan Medical Sciences University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Receiving hemodialysis therapy for at least 6 months; having dossier in hemodialysis ceneter; three time hemodialysis weekly and four hours for each session; hemoglobin less than 10 g/dl; history of seven weeks treatment with subcutaneous erythropoietin (2000 units, three times weekly at the end of each dialysis sessions). Exclusion criteria: Bone marrow malignancy; evidence of chronic infection; evidence of significant bleeding (decrease in Hb level > 2g/dL during the past 3 months); hemoglobinopathies; myelodysplastic syndrome.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin. Timepoint: Pre and Post of Intervention. Method of measurement: Blood Exam.;Ferrtin. Timepoint: Pre and Post of Intervention. Method of measurement: Blood Exam.;Total Iron Bonding Capasity. Timepoint: Pre and Post of Intervention. Method of measurement: Blood Exam. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Reza Shariati
Golestan Medical Sciences University
Outcome results
None listed